Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/43238
metadata.artigo.dc.title: | Prospects of nanomaterials-enabled biosensors for COVID-19 detection |
metadata.artigo.dc.creator: | Srivastava, Manish Srivastava, Neha Mishra, P. K. Malhotra, Bansi D. |
metadata.artigo.dc.subject: | Coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Nanomaterials Biosensors |
metadata.artigo.dc.publisher: | Elsevier |
metadata.artigo.dc.date.issued: | Feb-2021 |
metadata.artigo.dc.identifier.citation: | SRIVASTAVA, M. et al. Prospects of nanomaterials-enabled biosensors for COVID-19 detection. Science of The Total Environment, [S.l.], v. 754, Feb. 2021. |
metadata.artigo.dc.description.abstract: | We are currently facing the COVID-19 pandemic which is the consequence of severe acute respiratory syndrome coronavirus (SARS-CoV-2). Since no specific vaccines or drugs have been developed till date for the treatment of SARS-CoV-2 infection, early diagnosis is essential to further combat this pandemic. In this context, the reliable, rapid, and low-cost technique for SARS-CoV-2 diagnosis is the foremost priority. At present reverse transcription polymerase chain reaction (RT-PCR) is the reference technique presently being used for the detection of SARS-CoV-2 infection. However, in a number of cases, false results have been noticed in COVID-19 diagnosis. To develop advanced techniques, researchers are continuously working and in the series of constant efforts, nanomaterials-enabled biosensing approaches can be a hope to offer novel techniques that may perhaps meet the current demand of fast and early diagnosis of COVID-19 cases. This paper provides an overview of the COVID-19 pandemic and nanomaterials-enabled biosensing approaches that have been recently reported for the diagnosis of SARS-CoV-2. Though limited studies on the development of nanomaterials enabled biosensing techniques for the diagnosis of SARS-CoV-2 have been reported, this review summarizes nanomaterials mediated improved biosensing strategies and the possible mechanisms that may be responsible for the diagnosis of the COVID-19 disease. It is reviewed that nanomaterials e.g. gold nanostructures, lanthanide-doped polysterene nanoparticles (NPs), graphene and iron oxide NPs can be potentially used to develop advanced techniques offered by colorimetric, amperometric, impedimetric, fluorescence, and optomagnetic based biosensing of SARS-CoV-2. Finally, critical issues that are likely to accelerate the development of nanomaterials-enabled biosensing for SARS-CoV-2 infection have been discussed in detail. This review may serve as a guide for the development of advanced techniques for nanomaterials enabled biosensing to fulfill the present demand of low-cost, rapid and early diagnosis of COVID-19 infection. |
metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S0048969720358927 http://repositorio.ufla.br/jspui/handle/1/43238 |
metadata.artigo.dc.language: | en_US |
Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.